SCHEMBL11937037

SCHEMBL11937037

C=C1C(=O)NC(=O)NC1=O

nearest known ligand 0.53

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.53
OGT O15294 1/20 0.53
USP2 O75604 1/20 0.53
MAPT P10636 1/20 0.53
RECQL P46063 1/20 0.53
BLM P54132 1/20 0.53
METAP1 P53582 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14872072 0.77
SCHEMBL123424 0.76
SCHEMBL631517 0.76
SCHEMBL28733117 0.71 KDM4E (0.61) KDM4EOGTUSP2MAPTRECQL
SCHEMBL18567094 0.68
SCHEMBL12242976 0.67 ACVR1 (0.56) KDM4EMAPT
Alloxan SCHEMBL8924365 0.67 KDM4E (0.92) KDM4EOGTUSP2MAPTRECQL
SCHEMBL6988388 0.67
Alloxan SCHEMBL9093366 0.67 KDM4E (0.92) KDM4EOGTUSP2MAPTRECQL
Alloxan SCHEMBL28977108 0.67 KDM4E (0.92) KDM4EOGTUSP2MAPTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017474-A1 Novel Polycyclic Compound EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) 2022-01-20 US disclosed
WO-2020118933-A1 NOVEL POLYCYCLIC COMPOUND 优缔新材料科技(苏州)有限公司 2020-06-18 WO disclosed
US-9434699-B2 Iodine(III)-mediated radiofluorination THE GENERAL HOSPITAL CORPORATION (US) 2016-09-06 US disclosed
US-20150252007-A1 IODINE(III)-MEDIATED RADIOFLUORINATION THE GENERAL HOSPITAL CORPORATION 2015-09-10 US disclosed
US-8227690-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-07-24 US disclosed
US-8227690-B2 Dye-sensitized photoelectric conversion device NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-07-24 US disclosed
US-8039532-B2 Heterocyclic compound, ultraviolet absorbent and composition containing the same FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
US-8022293-B2 Using oxide semiconductor particles sensitized with an N,N,N*,N*-tetraphenyl-p-phenylenediamine derivative methine dye; solar cells with high stability and conversion efficiency NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-09-20 US disclosed
US-8022293-B2 Using oxide semiconductor particles sensitized with an N,N,N*,N*-tetraphenyl-p-phenylenediamine derivative methine dye; solar cells with high stability and conversion efficiency NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2011-09-20 US disclosed
US-20110008723-A1 TONER COLORANT, ELECTROPHOTOGRAPHIC TONER, TWO-COMPONENT DEVELOPER, IMAGE FORMING METHOD, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE RICOH COMPANY, LTD. (JP) 2011-01-13 US disclosed
US-20110008723-A1 TONER COLORANT, ELECTROPHOTOGRAPHIC TONER, TWO-COMPONENT DEVELOPER, IMAGE FORMING METHOD, IMAGE FORMING APPARATUS, AND PROCESS CARTRIDGE RICOH COMPANY, LTD. (JP) 2011-01-13 US disclosed
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME FUJIFILM CORPORATION (JP) 2010-08-19 US disclosed
US-20100130638-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-05-27 US disclosed
US-20100130638-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-05-27 US disclosed
US-20100025642-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2010-02-04 US disclosed
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-09-24 US disclosed
US-20080067476-A1 Dye-Sensitized Photoelectic Conversion Devices NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-03-20 US disclosed
US-20080067476-A1 Dye-Sensitized Photoelectic Conversion Devices NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-03-20 US disclosed
EP-1798804-A1 DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICES Nippon Kayaku Kabushiki Kaisha (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210762-A1 HETEROCYCLIC COMPOUND, ULTRAVIOLET ABSORBENT AND COMPOSITION CONTAINING THE SAME F12, F2, CYP24A1 KDM4E 3903/4885OGT 3733/4885USP2 2162/4885
US-20090240067-A1 METHOD OF PRODUCING A BISBENZODITHIOL COMPOUND SQOR, NQO1, PBRM1 KDM4E 3362/4885OGT 3143/4885USP2 2797/4885
US-20150252007-A1 IODINE(III)-MEDIATED RADIOFLUORINATION TPO, FLI1, SSTR3 KDM4E 1312/4885OGT 477/4885USP2 2734/4885
US-20220017474-A1 Novel Polycyclic Compound CUTA, DSG1, UACA KDM4E 1541/4885OGT 403/4885USP2 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.